Regenerative biology at UGA points to future of medicine
The Regenerative Bioscience Center at the University of Georgia is leading in Regenerative Medicine, a new area of life science and therapies.
The RBC is a vanguard of this science and is among the first to determine that neural stem cells can be generated in a lab. These RBC scientists created a therapy for stroke that should start clinical trials in 2023. This center seeks to research regenerative pathways and applications so that scientists and medical practitioners can regenerate tissue and bring healing to people with injury and/or disease.
Although biologic scientists focus research on stem cells for their enormous therapeutic potential, it is plausible that regenerative medicine can happen in other ways. All cells create small nano-sized bubbles, as well as proteins that can improve health outcomes for patients.
Natural killer cells defend the body against cancer, virus, and other threats. Researchers at UGA used a mouse model to determine that disease gets worse when natural killer cells are not present. This discovery can lead to new treatment(s) for Parkinson’s disease. They also revealed an application from blood using platelet lysate that can be given as an antibiotic on a variety of bacteria.
Research is highlighting new knowledge and insights into stem cell biology. It seems that a key finding is that mesenchymal stem cells release growth factors to orchestrate healing and not that stem cells replace damaged tissue.
We continue to see more advances in regenerative medicine as treatments. Please watch this space as the innovations move forward.
Our Editorial Note: Above is our brief summary of an article from Yahoo Finance. You may need a subscription to view the article in its entirety. Contact us if you would like to learn more about regenerative medicine and how it may help patients with their medical conditions.
MedAdvisor
info@medadvisor.co